Cannabis-Focused Investment Firm Silver Spike Looks To Raise US$85.0 Million On Its Nasdaq IPO

Management investment firm Silver Spike Investment Corp. (Nasdaq: SSIC) announced on Friday the pricing of its initial public offering on the Nasdaq Stock Market. The company went public on the US-based big board on February 4, 2022 under the ticker symbol “SSIC”.

The offering consists of 6,071,429 common shares at US$14.00 per share for potential total aggregate proceeds of US$85.0 million. The company also gave the underwriters the option to purchase additional 910,714 common shares at the same share price.

Stifel and Piper Sandler are managing the proposed offering as lead underwriters. 

The initial public offering is expected to close on February 9, 2022, subject to customary closing conditions. Net proceeds are expected to be used for its investment objective and strategies, which include debt and investments in the middle-market cannabis companies, and for general corporate purposes.

The newly-organized firm is being managed by health & wellness investment firm Silver Spike Capital.


Information for this briefing was found via Edagr and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Prices Are High, Experience Matters | Rob McLeod

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Recommended

Emerita Drills 1.4% Copper Over 9.2 Metres At El Cura In Advance Of Prefeasibility Study

Steadright Hints At Near Term Mineral Extraction From New Copper Valley Project

Related News

Gaming Giant Discord Reportedly Eyeing Public Listing

Social communications platform Discord is now preparing to enter the public markets with guidance from...

Saturday, March 29, 2025, 07:47:00 AM

SPAC Chavant Capital Acquisition Seeks To Raise US$80 Million In IPO

Special purpose acquisition company Chavant Capital Acquisition Corp. went public on Nasdaq Capital Market today....

Tuesday, July 20, 2021, 11:38:00 AM

Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs

Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO)...

Friday, May 6, 2022, 02:24:00 PM

Tech SPAC AxonPrime Infrastructure Acquisition Conducts US$150 Million IPO

Special purpose acquisition company AxonPrime Infrastructure Acquisition Corporation (Nasdaq: APMIU) started trading publicly on the...

Monday, August 16, 2021, 10:49:00 AM

Biotech Firm Blue Water Vaccines Prices US$20 Million IPO

Biopharmaceutical company Blue Water Vaccines, Inc. (Nasdaq: BWV) began trading on the Nasdaq Capital Market...

Monday, February 21, 2022, 04:33:00 PM